145 related articles for article (PubMed ID: 15934914)
1. MRSA--what is it, and how do we deal with the problem?
Barrett JF
Expert Opin Ther Targets; 2005 Apr; 9(2):253-65. PubMed ID: 15934914
[TBL] [Abstract][Full Text] [Related]
2. MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistance.
Barrett JF
Expert Opin Ther Targets; 2004 Dec; 8(6):515-9. PubMed ID: 15584858
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
Cunha BA
Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
[TBL] [Abstract][Full Text] [Related]
4. Isolation of methicillin-resistant Staphylococcus aureus from a postoperative wound infection in a horse.
Hartmann FA; Trostle SS; Klohnen AA
J Am Vet Med Assoc; 1997 Sep; 211(5):590-2. PubMed ID: 9290826
[TBL] [Abstract][Full Text] [Related]
5. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.
Hanberger H; Walther S; Leone M; Barie PS; Rello J; Lipman J; Marshall JC; Anzueto A; Sakr Y; Pickkers P; Felleiter P; Engoren M; Vincent JL;
Int J Antimicrob Agents; 2011 Oct; 38(4):331-5. PubMed ID: 21798720
[TBL] [Abstract][Full Text] [Related]
6. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
7. New and emerging treatment of Staphylococcus aureus infections in the hospital setting.
Moreillon P
Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():32-41. PubMed ID: 18318877
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S11-9; discussion S64-73. PubMed ID: 16813977
[TBL] [Abstract][Full Text] [Related]
9. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus.
John CC; Schreiber JR
Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units).
Meyer E; Schwab F; Gastmeier P; Jonas D; Rueden H; Daschner FD
Infect Control Hosp Epidemiol; 2006 Feb; 27(2):146-54. PubMed ID: 16465631
[TBL] [Abstract][Full Text] [Related]
11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
[TBL] [Abstract][Full Text] [Related]
12. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
[TBL] [Abstract][Full Text] [Related]
13. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis.
Millar BC; Prendergast BD; Moore JE
J Antimicrob Chemother; 2008 Jan; 61(1):1-7. PubMed ID: 17962214
[TBL] [Abstract][Full Text] [Related]
14. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
Kessler AT; Kourtis AP
Infection; 2007 Jun; 35(4):271-4. PubMed ID: 17646913
[TBL] [Abstract][Full Text] [Related]
15. Microbiology of antibiotic resistance in Staphylococcus aureus.
Appelbaum PC
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S165-70. PubMed ID: 17712742
[TBL] [Abstract][Full Text] [Related]
16. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
17. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
Phillips S; MacDougall C; Holdford DA
Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones.
Uete T; Matsuo K; Uete G
Jpn J Antibiot; 1992 Aug; 45(8):943-8. PubMed ID: 1433900
[TBL] [Abstract][Full Text] [Related]
19. The importance of the development of antibiotic resistance in Staphylococcus aureus.
Schito GC
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():3-8. PubMed ID: 16445718
[TBL] [Abstract][Full Text] [Related]
20. Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy.
Bush K; Heep M; Macielag MJ; Noel GJ
Expert Opin Investig Drugs; 2007 Apr; 16(4):419-29. PubMed ID: 17371191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
